Advertisement

Topics

Bispecific Antibodies: US FDA May Require Comparison To Approved Monospecific Product

18:37 EDT 29 Apr 2019 | SCRIP

When approved therapies target the same antigens as the investigational bispecific antibody, FDA may request a comparative clinical trial, draft...

      

Related Stories

 

Original Article: Bispecific Antibodies: US FDA May Require Comparison To Approved Monospecific Product

NEXT ARTICLE

More From BioPortfolio on "Bispecific Antibodies: US FDA May Require Comparison To Approved Monospecific Product"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...